The HCPLive Insights page is a resource for professional video interviews with leading clinical experts and investigators across all specialties of medicine.

Emerging Treatment Options for the Management of Moderate to Severe Psoriasis

February 18th 2022

Jerry Bagel, MD, MS, discusses the management of moderate-to-severe plaque psoriasis with a focus on newer agents currently in the drug approval pipeline.

Understanding and Treating Vitiligo

December 22nd 2021

An expert dermatologist provides insight on approaching the optimal treatment and management of vitiligo.

Management of Idiopathic Pulmonary Fibrosis

November 10th 2021

Experts in pulmonology provide insight on the diagnosis and optimal management of idiopathic pulmonary fibrosis (IPF).

Optimal Management of ADHD in Pediatric Population

November 9th 2021

Theresa R. Cerulli, MD, discusses current therapy options for the management of attention deficit hyperactivity disorders in the pediatric population.

Impact of Anemia & Hemolysis in Sickle Cell Disease

August 12th 2021

Sophie M. Lanzkron, MD, MHS; Jeffrey D. Lebensburger, DO, MSPH; and John J. Strouse, MD, PhD, explore current therapy options for the management of sickle cell disease and discuss the impact of anemia and hemolysis.

Case Based Insights: Expert Perspectives on the Treatment of Adult-Onset SMA

July 21st 2021

A key opinion leader in neurology, Arun S. Varadhachary, MD, PhD, reviews the case of a 28-year-old with spinal muscular atrophy and considers the role of nusinersen for patients with later-onset SMA.

Treatment of Rare Systemic Autoimmune Rheumatic Diseases (SARDS): Systemic Lupus Erythematous (SLE) and Idiopathic Inflammatory Myopathies

June 7th 2021

Expert rheumatologist, Kostas N. Botsoglou, MD provides an overview of the current therapeutic landscape for Systemic Autoimmune Rheumatic Diseases (SARDs) and discusses potential treatments on the horizon.

Cardiovascular Risk Management in Patients With Diabetes

June 4th 2021

Drs Marc P. Bonaca and Manesh R. Patel discuss the role of antiplatelet and anticoagulating agents in the treatment of patients with concurrent type 2 diabetes as per the 2021 ADA Standards of Medical Care in Diabetes.

Optimal Management of Opioid Induced Constipation

June 3rd 2021

Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, review currently available treatment options for the management of opioid-induced constipation.

A Review of Treatment Options for the Management of Sickle Cell Disease

May 24th 2021

Michael R. DeBaun, MD, MPH, reviews the use of recent FDA-approved therapies along with the conventional treatment options for the management of sickle cell disease.